Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MC230719 Window Of Opportunity Study Of GI-102 In Patients With Recurrent High-Grade Glioblastoma

NCT07301268 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07301268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07301268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MC230719 Window Of Opportunity Study Of GI-102 In Patients With Recurrent High-Grade Glioblastoma
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Recruiting
Start date
August 3, 2026
Completion date
September 1, 2032
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma, idh-wildtype, progressive astrocytoma, idh-mutant, grade 4, progressive glioblastoma, progressive gliosarcoma, recurrent astrocytoma, idh-mutant, grade 4, recurrent glioblastoma, idh-wildtype, recurrent gliosarcoma, resectable astrocytoma, resectable glioblastoma